Charles Schwab Investment Management Inc. Sells 9,071 Shares of Oscar Health, Inc. $OSCR

Charles Schwab Investment Management Inc. reduced its position in Oscar Health, Inc. (NYSE:OSCR) by 0.5% during the first quarter, according to its most recent 13F filing with the SEC. The firm owned 1,645,791 shares of the company’s stock after selling 9,071 shares during the period. Charles Schwab Investment Management Inc. owned 0.66% of Oscar Health worth $21,576,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Larson Financial Group LLC raised its stake in Oscar Health by 83,733.3% in the 1st quarter. Larson Financial Group LLC now owns 2,515 shares of the company’s stock valued at $33,000 after acquiring an additional 2,512 shares during the period. CWM LLC raised its stake in Oscar Health by 50.7% in the 1st quarter. CWM LLC now owns 3,204 shares of the company’s stock valued at $42,000 after acquiring an additional 1,078 shares during the period. Princeton Global Asset Management LLC bought a new stake in Oscar Health in the 1st quarter valued at about $59,000. GAMMA Investing LLC raised its stake in Oscar Health by 2,156.4% in the 1st quarter. GAMMA Investing LLC now owns 6,476 shares of the company’s stock valued at $85,000 after acquiring an additional 6,189 shares during the period. Finally, Tower Research Capital LLC TRC raised its stake in Oscar Health by 171.4% in the 4th quarter. Tower Research Capital LLC TRC now owns 6,627 shares of the company’s stock valued at $89,000 after acquiring an additional 4,185 shares during the period. 75.70% of the stock is currently owned by institutional investors.

Oscar Health Stock Up 0.9%

OSCR stock opened at $15.4140 on Friday. The company has a quick ratio of 0.86, a current ratio of 0.86 and a debt-to-equity ratio of 0.26. The firm has a market capitalization of $3.99 billion, a PE ratio of -19.03 and a beta of 1.86. Oscar Health, Inc. has a twelve month low of $11.20 and a twelve month high of $23.79. The stock has a 50-day simple moving average of $16.06 and a two-hundred day simple moving average of $14.79.

Oscar Health (NYSE:OSCR) last issued its quarterly earnings data on Wednesday, August 6th. The company reported ($0.89) EPS for the quarter, topping the consensus estimate of ($0.90) by $0.01. Oscar Health had a negative return on equity of 13.78% and a negative net margin of 1.50%.The company had revenue of $2.86 billion during the quarter, compared to analyst estimates of $2.88 billion. During the same quarter in the previous year, the firm earned $0.20 earnings per share. Oscar Health’s revenue was up 29.0% on a year-over-year basis. On average, equities analysts predict that Oscar Health, Inc. will post 0.69 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of equities research analysts recently issued reports on the company. Wells Fargo & Company cut Oscar Health from an “equal weight” rating to an “underweight” rating and lowered their price objective for the company from $16.00 to $10.00 in a research note on Friday, July 11th. UBS Group reaffirmed a “sell” rating and set a $11.00 target price (down previously from $15.00) on shares of Oscar Health in a report on Tuesday, July 15th. Raymond James Financial lowered Oscar Health from an “outperform” rating to a “market perform” rating in a report on Tuesday, June 24th. Wall Street Zen lowered Oscar Health from a “hold” rating to a “sell” rating in a report on Saturday, August 9th. Finally, Piper Sandler reduced their target price on Oscar Health from $14.00 to $13.00 and set a “neutral” rating for the company in a report on Thursday, August 14th. Four research analysts have rated the stock with a Hold rating and five have assigned a Sell rating to the company. According to data from MarketBeat.com, Oscar Health currently has an average rating of “Strong Sell” and a consensus price target of $12.07.

Oscar Health Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.